Araki, K.;                     Miyata, Y.;                     Ohba, K.;                     Nakamura, Y.;                     Matsuo, T.;                     Mochizuki, Y.;                     Sakai, H.    
        Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2. Medicines 2020, 7, 71.
    https://doi.org/10.3390/medicines7110071
    AMA Style
    
                                Araki K,                                 Miyata Y,                                 Ohba K,                                 Nakamura Y,                                 Matsuo T,                                 Mochizuki Y,                                 Sakai H.        
                Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2. Medicines. 2020; 7(11):71.
        https://doi.org/10.3390/medicines7110071
    
    Chicago/Turabian Style
    
                                Araki, Kyohei,                                 Yasuyoshi Miyata,                                 Kojiro Ohba,                                 Yuichiro Nakamura,                                 Tomohiro Matsuo,                                 Yasushi Mochizuki,                                 and Hideki Sakai.        
                2020. "Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2" Medicines 7, no. 11: 71.
        https://doi.org/10.3390/medicines7110071
    
    APA Style
    
                                Araki, K.,                                 Miyata, Y.,                                 Ohba, K.,                                 Nakamura, Y.,                                 Matsuo, T.,                                 Mochizuki, Y.,                                 & Sakai, H.        
        
        (2020). Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2. Medicines, 7(11), 71.
        https://doi.org/10.3390/medicines7110071